Share
To invite people, share this page:
COPY
More from Elsevier →
About
As the volume and complexity of scientific and regulatory data grows, AI has become a critical enabler of smarter, faster decision-making across preclinical, clinical, and regulatory affairs workflows.

Join us for a focused webinar exploring how PharmaPendium AI is advancing drug development by empowering pharmaceutical and biotech teams with rapid, data-driven insights.

This session will showcase how PharmaPendium AI leverages regulatory grade content including FDA Approval packages and advisory committee, EMA EPARs and machine learning to streamline research, enhance regulatory strategies, and reduce regulatory cycling. Whether you're designing studies, evaluating safety signals, or preparing regulatory submissions, learn how PharmaPendium AI can transform your approach to pharmaceutical R&D.

Can't attend live? Sign up and we'll send a link so you can watch the recording.
Agenda
  • Industry challenges in drug development and regulatory science
  • PharmaPendium AI in action
  • Key use cases and benefits supporting regulatory strategies
  • Q&A Session
Featured Presenters
  • Webinar hosting presenter

    Mirit Eldor

    Managing Director, Life Sciences Solutions, Elsevier
    Mirit Eldor is Managing Director, Life Sciences Solutions at Elsevier. Mirit is responsible for developing and enabling the execution of Elsevier’s strategy, and spends much of her time looking at new ways to bring together content, data,...
    Full Profile
  • Webinar hosting presenter

    Thomas Vargues

    Senior Product Manager , PharmaPendium
    Thomas Vargues is a Senior Product Manager at PharmaPendium, an Elsevier digital platform focused on regulatory information for the pharmaceutical industry. Thomas Vargues holds a PhD in biochemistry. In his role, he leads the development and...
    Full Profile